Antibiotic, produced Streptomyces lincolniensis, has a bacteriostatic effect. Suppress protein synthesis of bacteria due to reversible binding to 50S subunit ribosome disrupts the formation of peptide bonds.
Active against gram-positive cocci (Staphylococcus spp., Streptococcus spp., at e.g. Streptococcus pneumoniae); Bacillus anthracis, Mycoplasma spp., Corynebacterium diphtheriae, Clostridium perfringens, Clostridium tetani.
Effective in relation to Staphylococcus spp., resistant to penicillin, tetracyclines, chloramphenicol, streptomycin, cephalosporins (30% Staphylococcus spp., resistant to erythromycin, have cross resistance to lincomycin).
Does not apply to Enterococcus spp. (incl. Enterococcus faecalis), Gram-negative microorganisms, fungi, viruses, protozoa; is inferior in activity to erythromycin against spore forming anaerobes, Neisseria spp., Corynebacterium spp.
The optimum action is in alkaline medium (pH 8.0-8.5). Resistance to lincomycin develops slowly. In high doses has a bactericidal effect.